Page last updated: 2024-11-03

pf 5901 and Carcinoma in Situ

pf 5901 has been researched along with Carcinoma in Situ in 1 studies

alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol: structure given in first source; platelet activating factor antagonist

Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.

Research Excerpts

ExcerptRelevanceReference
"Pancreatic cancer has an abysmal prognosis because of late diagnosis."1.335-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions. ( Adrian, TE; Bell, RH; Buchler, MW; Ding, XZ; Friess, H; Grippo, P; Hennig, R; Rao, SM; Talamonti, MS, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hennig, R1
Grippo, P1
Ding, XZ1
Rao, SM1
Buchler, MW1
Friess, H1
Talamonti, MS1
Bell, RH1
Adrian, TE1

Other Studies

1 other study available for pf 5901 and Carcinoma in Situ

ArticleYear
5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions.
    Cancer research, 2005, Jul-15, Volume: 65, Issue:14

    Topics: Adenocarcinoma; Animals; Arachidonate 5-Lipoxygenase; Biomarkers, Tumor; Carcinogens; Carcinoma in S

2005